市場調査レポート

商品コード

1423572

インスリン送達デバイスの世界市場予測（～2030年）：製品、流通チャネル、エンドユーザー、地域別の分析

Insulin Delivery Devices Market Forecasts to 2030 - Global Analysis By Product (Insulin Pumps, Insulin Pens, Insulin Pen Needles, Insulin Syringes, Insulin Inhalers, Insulin Jet Injectors & Other Types), Distribution Channel, End User & By Geography

出版日: 2024年02月02日 | 発行: Stratistics Market Research Consulting

| ページ情報: 英文 200+ Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,150 650,554円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 822,990円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 995,426円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,175,700円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のインスリン送達デバイスの市場規模は、2023年に149億米ドルを占め、予測期間中にCAGR9.4％で成長し、2030年には280億米ドルに達すると予想されています。

インスリン送達デバイスは、糖尿病患者にインスリンを投与するために設計されたツールまたはシステムです。インスリンを体内に送り込むことで血糖値を調整するために使用されます。これらのデバイスには、インスリン注射器、インスリンペン、インスリンポンプ、インスリンジェットインジェクターなど、さまざまな形態があります。これらの器具は、インスリン投与のためのさまざまな方法を提供し、個人のライフスタイル、嗜好、およびインスリンの必要性に基づいて、自分の状態をより効果的に管理することを可能にします。

国際糖尿病連合（IDF）によると、2021年の成人糖尿病人口は約5億3,700万人で、この数は2030年には6億4,300万人増加すると予想されています。

糖尿病有病率の上昇

糖尿病有病率の増加は、インスリン送達デバイスの進歩に拍車をかけています。技術革新は多様なニーズに対応し、利便性と精度を提供しています。従来の注射器から先進的なインスリンポンプやペンに至るまで、テクノロジーは管理に革命をもたらしました。スマートデバイスは、モニタリングとデリバリーを統合し、患者の自律性を高めます。これらのデバイスは、アドヒアランスを改善するだけでなく、糖尿病を管理する個人のQOLを向上させ、糖尿病ケアに大きな進歩をもたらしています。

技術的問題

インスリン送達デバイスは、インスリン投与に影響を与える技術的な不具合に遭遇する可能性があります。誤作動はインスリンを正しく投与できず、高血糖や低血糖を引き起こす危険性があります。針の詰まりやポンプの閉塞のような機械的な不具合は、即時の交換を必要とし、インスリン治療の不便や中断を引き起こす可能性があります。このような技術的欠点は、シームレスで安全なインスリン送達を確実にするために、使用者の用心と定期的な機器点検の重要性を強調しています。これらが市場の成長を抑制する要因となっています。

促進的イニシアチブの採用

インスリン送達デバイスにおける促進的イニシアチブは、糖尿病治療に革命をもたらしました。スマートポンプ、持続グルコースモニタリングの統合、ユーザーフレンドリーなインターフェースなどの進歩は、管理を合理化します。さらに、自動インスリン送達アルゴリズムのような技術主導の機能は、正確でリアルタイムの調整を提供します。これらのイノベーションを取り入れることは、患者に力を与えるだけでなく、医療提供者と糖尿病を管理する個人の間の協力的なアプローチを促進します。これらが市場の成長を後押しする要因となっています。

高コスト

インスリン送達デバイスの高価格は重大な欠点をもたらし、主に糖尿病を管理する個人の入手可能性と購入能力に影響を与えます。この経済的負担は、しばしば必要不可欠な機器へのアクセスを制限し、不十分な治療や一貫性のない治療につながります。経済的な余裕がないために、血糖値の一貫したモニタリングや効果的なインスリン投与ができず、健康上の転帰が損なわれる可能性があります。こうした点が市場の成長を制限しています。

COVID-19の影響：

製造の停滞、輸送の問題、医療用品に対する需要の増加により、特定の器具の断続的な品不足と入手の遅れが生じました。パンデミックは機器の消毒と安全対策の重要性を強調しました。メーカーと使用者は、インスリン送達デバイスが適切に洗浄され、感染のリスクを最小限に抑えるためにメンテナンスされていることを確認することに、より多くの注意を払いました。

予測期間中、インスリンペン部門が最大となる見込み

予測期間中、インスリンペンセグメントは最大になると予想されます。その高い採用率、ユーザーフレンドリーなデザイン、消費者への訴求力の高まりなどが、このセグメントの売上高シェアが最も高くなる要因の一部です。高いシェアに大きく貢献しているのは、メーカーが技術革新と進歩に重点を置くようになっていることです。したがって、近い将来、製品の革新がインスリンペンの需要を促進すると予想されます。

予測期間中、在宅ケア分野のCAGRが最も高くなると予想される

在宅ケア分野は、糖尿病ケアに対する意識の高まりにより、予測期間中に最も高いCAGRが見込まれます。自宅で使用されるインスリンデバイスは、待ち時間、病院やクリニックの費用、訪問費用を削減します。ペン、注射器、ポンプの形をした最先端のガジェットは、コンパクトで携帯性に優れ、常に役に立ちます。使い勝手が向上し、利用しやすくなったため、インスリン使用者はセルフケアの糖尿病管理ソリューションを選ぶようになっています。

最大のシェアを占める地域

予測期間中、北米が最大の市場シェアを占めると予測されます。同地域の市場は、糖尿病有病率の増加、インスリン送達システムの技術的進歩、高齢化人口の拡大など様々な要因によって大きく成長しています。さらに、革新的なインスリン送達デバイスを開発するための医療提供者、メーカー、研究機関の連携が、同地域の市場成長をさらに促進しています。

CAGRが最も高い地域：

アジア太平洋は、予測期間中に最も高いCAGRを維持すると予測されています。同地域の市場は、糖尿病有病率の上昇、先進的なインスリン送達技術に関する認知度の向上、いくつかの国における医療インフラの改善など、さまざまな要因によって著しい成長を遂げています。さらに、糖尿病管理を促進する政府の取り組みや、インスリン送達システムの技術的進歩も市場の拡大に寄与しています。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場企業の包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東とアフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第9章主な発展

協定、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品の発売
事業拡大
その他の主要戦略

第10章企業プロファイル

Abbott Laboratories
Novo Nordisk A/S
Wockhardt Ltd.
Medtronic
F. Hoffmann-La Roche, Ltd.
Becton, Dickinson and Company
Sanofi
Eli Lilly and Company
Biocon Ltd.
Roche
Insulet Corporation
B Braun Melsungen AG
Tandem Diabetes Care
Embecta Corporation
Ypsomed AG

図表

List of Tables

Table 1 Global Insulin Delivery Devices Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Insulin Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
Table 3 Global Insulin Delivery Devices Market Outlook, By Insulin Pumps (2021-2030) ($MN)
Table 4 Global Insulin Delivery Devices Market Outlook, By Tubeless (2021-2030) ($MN)
Table 5 Global Insulin Delivery Devices Market Outlook, By Tethered (2021-2030) ($MN)
Table 6 Global Insulin Delivery Devices Market Outlook, By Insulin Pens (2021-2030) ($MN)
Table 7 Global Insulin Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
Table 8 Global Insulin Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
Table 9 Global Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2021-2030) ($MN)
Table 10 Global Insulin Delivery Devices Market Outlook, By Safety (2021-2030) ($MN)
Table 11 Global Insulin Delivery Devices Market Outlook, By Standard (2021-2030) ($MN)
Table 12 Global Insulin Delivery Devices Market Outlook, By Insulin Syringes (2021-2030) ($MN)
Table 13 Global Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2021-2030) ($MN)
Table 14 Global Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2021-2030) ($MN)
Table 15 Global Insulin Delivery Devices Market Outlook, By Other Types (2021-2030) ($MN)
Table 16 Global Insulin Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 17 Global Insulin Delivery Devices Market Outlook, By Online Sales (2021-2030) ($MN)
Table 18 Global Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 19 Global Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 20 Global Insulin Delivery Devices Market Outlook, By End User (2021-2030) ($MN)
Table 21 Global Insulin Delivery Devices Market Outlook, By Homecare (2021-2030) ($MN)
Table 22 Global Insulin Delivery Devices Market Outlook, By Clinics (2021-2030) ($MN)
Table 23 Global Insulin Delivery Devices Market Outlook, By Other End Users (2021-2030) ($MN)
Table 24 North America Insulin Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
Table 25 North America Insulin Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
Table 26 North America Insulin Delivery Devices Market Outlook, By Insulin Pumps (2021-2030) ($MN)
Table 27 North America Insulin Delivery Devices Market Outlook, By Tubeless (2021-2030) ($MN)
Table 28 North America Insulin Delivery Devices Market Outlook, By Tethered (2021-2030) ($MN)
Table 29 North America Insulin Delivery Devices Market Outlook, By Insulin Pens (2021-2030) ($MN)
Table 30 North America Insulin Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
Table 31 North America Insulin Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
Table 32 North America Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2021-2030) ($MN)
Table 33 North America Insulin Delivery Devices Market Outlook, By Safety (2021-2030) ($MN)
Table 34 North America Insulin Delivery Devices Market Outlook, By Standard (2021-2030) ($MN)
Table 35 North America Insulin Delivery Devices Market Outlook, By Insulin Syringes (2021-2030) ($MN)
Table 36 North America Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2021-2030) ($MN)
Table 37 North America Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2021-2030) ($MN)
Table 38 North America Insulin Delivery Devices Market Outlook, By Other Types (2021-2030) ($MN)
Table 39 North America Insulin Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 40 North America Insulin Delivery Devices Market Outlook, By Online Sales (2021-2030) ($MN)
Table 41 North America Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 42 North America Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 43 North America Insulin Delivery Devices Market Outlook, By End User (2021-2030) ($MN)
Table 44 North America Insulin Delivery Devices Market Outlook, By Homecare (2021-2030) ($MN)
Table 45 North America Insulin Delivery Devices Market Outlook, By Clinics (2021-2030) ($MN)
Table 46 North America Insulin Delivery Devices Market Outlook, By Other End Users (2021-2030) ($MN)
Table 47 Europe Insulin Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
Table 48 Europe Insulin Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
Table 49 Europe Insulin Delivery Devices Market Outlook, By Insulin Pumps (2021-2030) ($MN)
Table 50 Europe Insulin Delivery Devices Market Outlook, By Tubeless (2021-2030) ($MN)
Table 51 Europe Insulin Delivery Devices Market Outlook, By Tethered (2021-2030) ($MN)
Table 52 Europe Insulin Delivery Devices Market Outlook, By Insulin Pens (2021-2030) ($MN)
Table 53 Europe Insulin Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
Table 54 Europe Insulin Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
Table 55 Europe Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2021-2030) ($MN)
Table 56 Europe Insulin Delivery Devices Market Outlook, By Safety (2021-2030) ($MN)
Table 57 Europe Insulin Delivery Devices Market Outlook, By Standard (2021-2030) ($MN)
Table 58 Europe Insulin Delivery Devices Market Outlook, By Insulin Syringes (2021-2030) ($MN)
Table 59 Europe Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2021-2030) ($MN)
Table 60 Europe Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2021-2030) ($MN)
Table 61 Europe Insulin Delivery Devices Market Outlook, By Other Types (2021-2030) ($MN)
Table 62 Europe Insulin Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 63 Europe Insulin Delivery Devices Market Outlook, By Online Sales (2021-2030) ($MN)
Table 64 Europe Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 65 Europe Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 66 Europe Insulin Delivery Devices Market Outlook, By End User (2021-2030) ($MN)
Table 67 Europe Insulin Delivery Devices Market Outlook, By Homecare (2021-2030) ($MN)
Table 68 Europe Insulin Delivery Devices Market Outlook, By Clinics (2021-2030) ($MN)
Table 69 Europe Insulin Delivery Devices Market Outlook, By Other End Users (2021-2030) ($MN)
Table 70 Asia Pacific Insulin Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
Table 71 Asia Pacific Insulin Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
Table 72 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Pumps (2021-2030) ($MN)
Table 73 Asia Pacific Insulin Delivery Devices Market Outlook, By Tubeless (2021-2030) ($MN)
Table 74 Asia Pacific Insulin Delivery Devices Market Outlook, By Tethered (2021-2030) ($MN)
Table 75 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Pens (2021-2030) ($MN)
Table 76 Asia Pacific Insulin Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
Table 77 Asia Pacific Insulin Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
Table 78 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2021-2030) ($MN)
Table 79 Asia Pacific Insulin Delivery Devices Market Outlook, By Safety (2021-2030) ($MN)
Table 80 Asia Pacific Insulin Delivery Devices Market Outlook, By Standard (2021-2030) ($MN)
Table 81 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Syringes (2021-2030) ($MN)
Table 82 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2021-2030) ($MN)
Table 83 Asia Pacific Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2021-2030) ($MN)
Table 84 Asia Pacific Insulin Delivery Devices Market Outlook, By Other Types (2021-2030) ($MN)
Table 85 Asia Pacific Insulin Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 86 Asia Pacific Insulin Delivery Devices Market Outlook, By Online Sales (2021-2030) ($MN)
Table 87 Asia Pacific Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 88 Asia Pacific Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 89 Asia Pacific Insulin Delivery Devices Market Outlook, By End User (2021-2030) ($MN)
Table 90 Asia Pacific Insulin Delivery Devices Market Outlook, By Homecare (2021-2030) ($MN)
Table 91 Asia Pacific Insulin Delivery Devices Market Outlook, By Clinics (2021-2030) ($MN)
Table 92 Asia Pacific Insulin Delivery Devices Market Outlook, By Other End Users (2021-2030) ($MN)
Table 93 South America Insulin Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
Table 94 South America Insulin Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
Table 95 South America Insulin Delivery Devices Market Outlook, By Insulin Pumps (2021-2030) ($MN)
Table 96 South America Insulin Delivery Devices Market Outlook, By Tubeless (2021-2030) ($MN)
Table 97 South America Insulin Delivery Devices Market Outlook, By Tethered (2021-2030) ($MN)
Table 98 South America Insulin Delivery Devices Market Outlook, By Insulin Pens (2021-2030) ($MN)
Table 99 South America Insulin Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
Table 100 South America Insulin Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
Table 101 South America Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2021-2030) ($MN)
Table 102 South America Insulin Delivery Devices Market Outlook, By Safety (2021-2030) ($MN)
Table 103 South America Insulin Delivery Devices Market Outlook, By Standard (2021-2030) ($MN)
Table 104 South America Insulin Delivery Devices Market Outlook, By Insulin Syringes (2021-2030) ($MN)
Table 105 South America Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2021-2030) ($MN)
Table 106 South America Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2021-2030) ($MN)
Table 107 South America Insulin Delivery Devices Market Outlook, By Other Types (2021-2030) ($MN)
Table 108 South America Insulin Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 109 South America Insulin Delivery Devices Market Outlook, By Online Sales (2021-2030) ($MN)
Table 110 South America Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 111 South America Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 112 South America Insulin Delivery Devices Market Outlook, By End User (2021-2030) ($MN)
Table 113 South America Insulin Delivery Devices Market Outlook, By Homecare (2021-2030) ($MN)
Table 114 South America Insulin Delivery Devices Market Outlook, By Clinics (2021-2030) ($MN)
Table 115 South America Insulin Delivery Devices Market Outlook, By Other End Users (2021-2030) ($MN)
Table 116 Middle East & Africa Insulin Delivery Devices Market Outlook, By Country (2021-2030) ($MN)
Table 117 Middle East & Africa Insulin Delivery Devices Market Outlook, By Product (2021-2030) ($MN)
Table 118 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Pumps (2021-2030) ($MN)
Table 119 Middle East & Africa Insulin Delivery Devices Market Outlook, By Tubeless (2021-2030) ($MN)
Table 120 Middle East & Africa Insulin Delivery Devices Market Outlook, By Tethered (2021-2030) ($MN)
Table 121 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Pens (2021-2030) ($MN)
Table 122 Middle East & Africa Insulin Delivery Devices Market Outlook, By Reusable (2021-2030) ($MN)
Table 123 Middle East & Africa Insulin Delivery Devices Market Outlook, By Disposable (2021-2030) ($MN)
Table 124 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Pen Needles (2021-2030) ($MN)
Table 125 Middle East & Africa Insulin Delivery Devices Market Outlook, By Safety (2021-2030) ($MN)
Table 126 Middle East & Africa Insulin Delivery Devices Market Outlook, By Standard (2021-2030) ($MN)
Table 127 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Syringes (2021-2030) ($MN)
Table 128 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Inhalers (2021-2030) ($MN)
Table 129 Middle East & Africa Insulin Delivery Devices Market Outlook, By Insulin Jet Injectors (2021-2030) ($MN)
Table 130 Middle East & Africa Insulin Delivery Devices Market Outlook, By Other Types (2021-2030) ($MN)
Table 131 Middle East & Africa Insulin Delivery Devices Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 132 Middle East & Africa Insulin Delivery Devices Market Outlook, By Online Sales (2021-2030) ($MN)
Table 133 Middle East & Africa Insulin Delivery Devices Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 134 Middle East & Africa Insulin Delivery Devices Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 135 Middle East & Africa Insulin Delivery Devices Market Outlook, By End User (2021-2030) ($MN)
Table 136 Middle East & Africa Insulin Delivery Devices Market Outlook, By Homecare (2021-2030) ($MN)
Table 137 Middle East & Africa Insulin Delivery Devices Market Outlook, By Clinics (2021-2030) ($MN)
Table 138 Middle East & Africa Insulin Delivery Devices Market Outlook, By Other End Users (2021-2030) ($MN)

Product Code: SMRC24806

According to Stratistics MRC, the Global Insulin Delivery Devices Market is accounted for $14.9 billion in 2023 and is expected to reach $28.0 billion by 2030 growing at a CAGR of 9.4% during the forecast period. Insulin delivery devices are tools or systems designed to administer insulin to individuals with diabetes. They're used to regulate blood sugar levels by delivering insulin into the body. These devices come in various forms, such as insulin syringes, insulin pens, insulin pumps, and insulin jet injectors. They provide different methods for insulin administration, allowing individuals to manage their condition more effectively based on their lifestyle, preferences, and insulin needs.

According to International Diabetes Federation (IDF), the adult diabetes population in 2021 was approximately 537 million, and this number is expected to increase by 643 million in 2030.

Market Dynamics:

Driver:

Rising prevalence of diabetes

The rising prevalence of diabetes has fuelled advancements in insulin delivery devices. Innovations cater to diverse needs, offering convenience and precision. From traditional syringes to advanced insulin pumps and pens, technology has revolutionized management. Smart devices integrate monitoring with delivery, enhancing patient autonomy. These devices not only improve adherence but also enhance quality of life for individuals managing diabetes, marking a significant stride in diabetes care.

Restraint:

Technical issues

Insulin delivery devices can encounter technical glitches impacting insulin administration. Malfunctions pose risks of incorrect insulin delivery, leading to hyper or hypoglycemia. Mechanical failures, like needle jams or pump blockages, necessitate immediate replacement, potentially causing inconvenience or interruptions in insulin therapy. These technical drawbacks highlight the importance of user vigilance and regular device checks to ensure seamless and safe insulin delivery. These are the factors restraining the growth of the market.

Opportunity:

Adoption of facilitative initiatives

Facilitative initiatives in insulin delivery devices have revolutionized diabetic care. Advances like smart pumps, continuous glucose monitoring integration, and user-friendly interfaces streamline management. Additionally, tech-driven features, such as automated insulin delivery algorithms, offer precise, real-time adjustments. Embracing these innovations not only empowers patients but also fosters a collaborative approach between healthcare providers and individuals managing diabetes. These are the factors propelling the growth of the market.

Threat:

High cost

The high cost of insulin delivery devices poses significant disadvantages, primarily affecting accessibility and affordability for individuals managing diabetes. This financial burden often restricts access to essential equipment, leading to inadequate or inconsistent treatment. Limited affordability can result in compromised health outcomes due to the inability to consistently monitor blood sugar levels or administer insulin effectively. These are the aspects limiting the growth of the market.

Covid-19 Impact:

Manufacturing slowdowns, transportation issues, and increased demand for medical supplies led to intermittent shortages and delays in availability for certain devices. The pandemic emphasized the importance of device sanitization and safety measures. Manufacturers and users paid more attention to ensuring that insulin delivery devices were properly cleaned and maintained to minimize the risk of infection.

The insulin pens segment is expected to be the largest during the forecast period

The insulin pens segment is expected to be the largest during the forecast period. ts advantages over other products. Its high adoption rate, user-friendly design, and growing consumer appeal were some of the factors that led to this segment's highest revenue share. A significant contributing aspect to the high share is the increasing emphasis that manufacturers are placing on innovation and advances. Therefore, it is anticipated that in the near future, product innovations will drive the demand for insulin pens.

The home care segment is expected to have the highest CAGR during the forecast period

The home care segment is expected to have the highest CAGR during the forecast period due to increasing awareness of diabetes care. Insulin devices used at home reduce waiting times, hospital or clinic fees, and visitation expenses. The cutting-edge gadgets, which come in the form of pens, injectors, and pumps, are compact, extremely portable, and always useful. Because of their increased usability and increased accessibility, insulin users are choosing self-care diabetes control solutions.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. The market in the region has been significant, driven by various factors such as the increasing prevalence of diabetes, technological advancements in insulin delivery systems, and the growing aging population. Additionally, collaborations between healthcare providers, manufacturers, and research institutions for developing innovative insulin delivery devices have further propelled market growth in the region.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. The market in the region has been witnessing significant growth due to various factors such as the rising prevalence of diabetes, increasing awareness about advanced insulin delivery technologies, and improving healthcare infrastructure in several countries. Moreover, government initiatives promoting diabetes management and technological advancements in insulin delivery systems contribute to the market's expansion.

Key players in the market

Some of the key players in Insulin Delivery Devices market include Abbott Laboratories, Novo Nordisk A/S, Wockhardt Ltd., Medtronic, F. Hoffmann-La Roche, Ltd., Becton, Dickinson and Company, Sanofi, Eli Lilly and Company, Biocon Ltd., Roche, Insulet Corporation, B Braun Melsungen AG, Tandem Diabetes Care, Embecta Corporation and Ypsomed AG.

Key Developments:

In June 2023, Novo Nordisk entered negotiations of acquiring BIOCORP, which specialized in the design and development of medical devices. This was done for the development of FlexTouch Pen with Mallya, an add-on Bluetooth device.

In Feb 2023, Lilly and IABL, the largest healthcare provider collaborated to provide high-quality and affordable insulin in Bangladesh.

Types Covered:

Insulin Pumps
Insulin Pens
Insulin Pen Needles
Insulin Syringes
Insulin Inhalers
Insulin Jet Injectors
Other Types

Distribution Channels Covered:

Online Sales
Hospital Pharmacies
Retail Pharmacies

End Users Covered:

Homecare
Clinics
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Insulin Delivery Devices Market, By Product

5.1 Introduction
5.2 Insulin Pumps
- 5.2.1 Tubeless
- 5.2.2 Tethered
5.3 Insulin Pens
- 5.3.1 Reusable
- 5.3.2 Disposable
5.4 Insulin Pen Needles
- 5.4.1 Safety
- 5.4.2 Standard
5.5 Insulin Syringes
5.6 Insulin Inhalers
5.7 Insulin Jet Injectors
5.8 Other Types

6 Global Insulin Delivery Devices Market, By Distribution Channel

6.1 Introduction
6.2 Online Sales
6.3 Hospital Pharmacies
6.4 Retail Pharmacies

7 Global Insulin Delivery Devices Market, By End User

7.1 Introduction
7.2 Homecare
7.3 Clinics
7.4 Other End Users

8 Global Insulin Delivery Devices Market, By Geography

8.1 Introduction
8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa

9 Key Developments

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling

10.1 Abbott Laboratories
10.2 Novo Nordisk A/S
10.3 Wockhardt Ltd.
10.4 Medtronic
10.5 F. Hoffmann-La Roche, Ltd.
10.6 Becton, Dickinson and Company
10.7 Sanofi
10.8 Eli Lilly and Company
10.9 Biocon Ltd.
10.10 Roche
10.11 Insulet Corporation
10.12 B Braun Melsungen AG
10.13 Tandem Diabetes Care
10.14 Embecta Corporation
10.15 Ypsomed AG

インスリン送達デバイスの世界市場予測（～2030年）：製品、流通チャネル、エンドユーザー、地域別の分析

Insulin Delivery Devices Market Forecasts to 2030 - Global Analysis By Product (Insulin Pumps, Insulin Pens, Insulin Pen Needles, Insulin Syringes, Insulin Inhalers, Insulin Jet Injectors & Other Types), Distribution Channel, End User & By Geography

COVID-19の影響：

最大のシェアを占める地域

CAGRが最も高い地域：

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

第4章 ポーターのファイブフォース分析

第5章 世界のインスリン送達デバイス市場：製品別

第6章 世界のインスリン送達デバイス市場：流通チャネル別

第7章 世界のインスリン送達デバイス市場：エンドユーザー別

第8章 世界のインスリン送達デバイス市場：地域別

第9章 主な発展

第10章 企業プロファイル